Design, Synthesis and SAR Study of Novel Trisubstituted Pyrimidine Amide Derivatives as CCR4 Antagonists

The design, synthesis and structure-activity relationship studies of some novel trisubstituted pyrimidine amide derivatives prepared as CCR4 antagonists are described. The activities of these compounds were evaluated by the CCR4-MDC chemotaxis inhibition assay. Compound 1, which we have previously r...

Full description

Bibliographic Details
Main Authors: Libao Xu, Yang Zhang, Wenjie Dai, Ying Wang, Dan Jiang, Lili Wang, Junhai Xiao, Xiaohong Yang, Song Li
Format: Article
Language:English
Published: MDPI AG 2014-03-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/19/3/3539
id doaj-a0275585939f4778b255f39fb7db2055
record_format Article
spelling doaj-a0275585939f4778b255f39fb7db20552020-11-24T22:57:22ZengMDPI AGMolecules1420-30492014-03-011933539355110.3390/molecules19033539molecules19033539Design, Synthesis and SAR Study of Novel Trisubstituted Pyrimidine Amide Derivatives as CCR4 AntagonistsLibao Xu0Yang Zhang1Wenjie Dai2Ying Wang3Dan Jiang4Lili Wang5Junhai Xiao6Xiaohong Yang7Song Li8School of Pharmaceutical Sciences, Jilin University, Changchun 130021, ChinaDepartment of Immunology, School of Basic Medical Sciences, Key Laboratory of Medical Immunology, Ministry of Health, Peking University Health Science Center, Beijing 100191, ChinaShenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, ChinaDepartment of Immunology, School of Basic Medical Sciences, Key Laboratory of Medical Immunology, Ministry of Health, Peking University Health Science Center, Beijing 100191, ChinaLaboratory of Computer-Aided Drug Design & Discovery, Beijing Institute of Pharmacology & Toxicology, Beijing 100850, ChinaLaboratory of Computer-Aided Drug Design & Discovery, Beijing Institute of Pharmacology & Toxicology, Beijing 100850, ChinaLaboratory of Computer-Aided Drug Design & Discovery, Beijing Institute of Pharmacology & Toxicology, Beijing 100850, ChinaSchool of Pharmaceutical Sciences, Jilin University, Changchun 130021, ChinaSchool of Pharmaceutical Sciences, Jilin University, Changchun 130021, ChinaThe design, synthesis and structure-activity relationship studies of some novel trisubstituted pyrimidine amide derivatives prepared as CCR4 antagonists are described. The activities of these compounds were evaluated by the CCR4-MDC chemotaxis inhibition assay. Compound 1, which we have previously reported as a potent antagonist of CCR4, was employed as the positive control. The results indicated that most of the synthesized compounds exhibited some chemotaxis inhibition activity against CCR4. Of these new compounds, compounds 6c, 12a and 12b, with IC50 values of 0.064, 0.077 and 0.069 μM, respectively, showed higher or similar activity compared with compound 1 (IC50 of 0.078 μM). These compounds provide a basis for further structural modifications. The systematic structure-activity relationship of these trisubstituted pyrimidine amide derivatives was discussed based on the obtained experimental data. The results from the SAR study may be useful for identifying more potent CCR4 antagonists.http://www.mdpi.com/1420-3049/19/3/3539antagonistspyrimidine amidessynthesisstructure-activity relationship
collection DOAJ
language English
format Article
sources DOAJ
author Libao Xu
Yang Zhang
Wenjie Dai
Ying Wang
Dan Jiang
Lili Wang
Junhai Xiao
Xiaohong Yang
Song Li
spellingShingle Libao Xu
Yang Zhang
Wenjie Dai
Ying Wang
Dan Jiang
Lili Wang
Junhai Xiao
Xiaohong Yang
Song Li
Design, Synthesis and SAR Study of Novel Trisubstituted Pyrimidine Amide Derivatives as CCR4 Antagonists
Molecules
antagonists
pyrimidine amides
synthesis
structure-activity relationship
author_facet Libao Xu
Yang Zhang
Wenjie Dai
Ying Wang
Dan Jiang
Lili Wang
Junhai Xiao
Xiaohong Yang
Song Li
author_sort Libao Xu
title Design, Synthesis and SAR Study of Novel Trisubstituted Pyrimidine Amide Derivatives as CCR4 Antagonists
title_short Design, Synthesis and SAR Study of Novel Trisubstituted Pyrimidine Amide Derivatives as CCR4 Antagonists
title_full Design, Synthesis and SAR Study of Novel Trisubstituted Pyrimidine Amide Derivatives as CCR4 Antagonists
title_fullStr Design, Synthesis and SAR Study of Novel Trisubstituted Pyrimidine Amide Derivatives as CCR4 Antagonists
title_full_unstemmed Design, Synthesis and SAR Study of Novel Trisubstituted Pyrimidine Amide Derivatives as CCR4 Antagonists
title_sort design, synthesis and sar study of novel trisubstituted pyrimidine amide derivatives as ccr4 antagonists
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2014-03-01
description The design, synthesis and structure-activity relationship studies of some novel trisubstituted pyrimidine amide derivatives prepared as CCR4 antagonists are described. The activities of these compounds were evaluated by the CCR4-MDC chemotaxis inhibition assay. Compound 1, which we have previously reported as a potent antagonist of CCR4, was employed as the positive control. The results indicated that most of the synthesized compounds exhibited some chemotaxis inhibition activity against CCR4. Of these new compounds, compounds 6c, 12a and 12b, with IC50 values of 0.064, 0.077 and 0.069 μM, respectively, showed higher or similar activity compared with compound 1 (IC50 of 0.078 μM). These compounds provide a basis for further structural modifications. The systematic structure-activity relationship of these trisubstituted pyrimidine amide derivatives was discussed based on the obtained experimental data. The results from the SAR study may be useful for identifying more potent CCR4 antagonists.
topic antagonists
pyrimidine amides
synthesis
structure-activity relationship
url http://www.mdpi.com/1420-3049/19/3/3539
work_keys_str_mv AT libaoxu designsynthesisandsarstudyofnoveltrisubstitutedpyrimidineamidederivativesasccr4antagonists
AT yangzhang designsynthesisandsarstudyofnoveltrisubstitutedpyrimidineamidederivativesasccr4antagonists
AT wenjiedai designsynthesisandsarstudyofnoveltrisubstitutedpyrimidineamidederivativesasccr4antagonists
AT yingwang designsynthesisandsarstudyofnoveltrisubstitutedpyrimidineamidederivativesasccr4antagonists
AT danjiang designsynthesisandsarstudyofnoveltrisubstitutedpyrimidineamidederivativesasccr4antagonists
AT liliwang designsynthesisandsarstudyofnoveltrisubstitutedpyrimidineamidederivativesasccr4antagonists
AT junhaixiao designsynthesisandsarstudyofnoveltrisubstitutedpyrimidineamidederivativesasccr4antagonists
AT xiaohongyang designsynthesisandsarstudyofnoveltrisubstitutedpyrimidineamidederivativesasccr4antagonists
AT songli designsynthesisandsarstudyofnoveltrisubstitutedpyrimidineamidederivativesasccr4antagonists
_version_ 1725651064228675584